Physician profile
Guang Yang
NPI 1396767612
$987.21
in general payments reported to CMS, 2019-2025
10 companies · $613 in 2025
The $613 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.14 · 2021: $25.00 · 2022: $39.14 · 2023: $17.79 · 2024: $278 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $250.11 | 2024-2025 | Qutenza |
| Abbvie INC. | $207.49 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $201.34 | 2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $129.99 | 2025 | Vyrsa V1 |
| Grt US Holding, INC. | $64.14 | 2021-2022 | |
| Si-Bone, INC. | $40.85 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $40.45 | 2024-2025 | |
| Nevro Corp. | $23.86 | 2024 | Senza |
| Pacira Therapeutics, INC. | $15.14 | 2019 | |
| Nalu Medical, INC. | $13.84 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guang Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.